The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with rituximab plus bendamustine (R-Benda), dexamethasone, rituximab, cyclophosphamide (DRC), and bortezomib, dexamethasone, rituximab (BDR) as primary therapy in patients with Waldenstrom macroglobulinemia (WM).
 
Jithma P. Abeykoon
No Relationships to Disclose
 
Saurabh Zanwar
No Relationships to Disclose
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); LAM Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Shaji Kumar
Honoraria - Dr. Reddy's
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
 
Carrie A. Thompson
No Relationships to Disclose
 
Thomas Matthew Habermann
No Relationships to Disclose
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
Francis Buadi
No Relationships to Disclose
 
Ronald S. Go
No Relationships to Disclose
 
Wilson I. Gonsalves
Consulting or Advisory Role - Amgen (Inst)
 
Nelson Leung
Research Funding - Omeros
 
Angela Dispenzieri
Consulting or Advisory Role - GlaxoSmithKline (Inst); Prothena (Inst)
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Martha Lacy
Research Funding - Celgene (Inst)
 
Rahma M. Warsame
No Relationships to Disclose
 
David James Inwards
No Relationships to Disclose
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date
 
Robert A. Kyle
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Pfizer; Pharmacyclics
 
Morie A. Gertz
Honoraria - Annexon Biosciences; Apellis Pharmaceuticals; Celgene; ION Pharma; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sandoz; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Prashant Kapoor
Honoraria - Takeda
Consulting or Advisory Role - Sanofi (Inst)
Speakers' Bureau - Axis Medical Education
Research Funding - Amgen (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Axis Pharma; GlaxoSmithKline; Janssen; Sanofi; Takeda